Gilder Gagnon Howe & Co’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $602K | Sell |
|
|||||
|
2024
Q4 | $1.17M | Sell |
|
|||||
|
2024
Q3 | $1.21M | Sell |
|
|||||
|
2024
Q2 | $1.98M | Sell |
|
|||||
|
2024
Q1 | $2.23M | Sell |
|
|||||
|
2023
Q4 | $1.7M | Buy |
|
|||||
|
2023
Q3 | $2.01M | Buy |
|
|||||
|
2023
Q2 | $1.87M | Sell |
|
|||||
|
2023
Q1 | $2.31M | Sell |
|
|||||
|
2022
Q4 | $2.2M | Sell |
|
|||||
|
2022
Q3 | $1.88M | Buy |
|
|||||
|
2022
Q2 | $562K | Sell |
|
|||||
|
2022
Q1 | $586K | Sell |
|
|||||
|
2021
Q4 | $703K | Sell |
|
|||||
|
2021
Q3 | $725K | Sell |
|
|||||
|
2021
Q2 | $626K | Sell |
|
|||||
|
2021
Q1 | $600K | Sell |
|
|||||
|
2020
Q4 | $110M | Sell |
|
|||||
|
2020
Q3 | $121M | Sell |
|
|||||
|
2020
Q2 | $144M | Sell |
|
|||||
|
2020
Q1 | $90.8M | Sell |
|
|||||
|
2019
Q4 | $122M | Sell |
|
|||||
|
2019
Q3 | $71.6M | Sell |
|
|||||
|
2019
Q2 | $151M | Sell |
|
|||||
|
2019
Q1 | $118M | Buy |
|
|||||
|
2018
Q4 | $106M | Sell |
|
|||||
|
2018
Q3 | $158M | Sell |
|
|||||
|
2018
Q2 | $130M | Sell |
|
|||||
|
2018
Q1 | $74M | Buy |
|
|||||
|
2017
Q4 | $48.6M | Buy |
|
|||||
|
2017
Q3 | $24.2M | Buy |
|
|||||
|
2017
Q2 | $487K | Sell |
|
|||||
|
2017
Q1 | $434K | Buy |
|
|||||
|
2016
Q4 | $299K | Sell |
|
|||||
|
2016
Q3 | $991K | Sell |
|
|||||
|
2016
Q2 | $343K | Sell |
|
|||||
|
2016
Q1 | $352K | Sell |
|
|||||
|
2015
Q4 | $698K | Buy |
|
|||||
|
2015
Q3 | $267K | Sell |
|
|||||
|
2015
Q2 | $254K | Sell |
|
|||||
|
2015
Q1 | $228K | Sell |
|
|||||
|
2014
Q4 | $6.39M | Sell |
|
|||||
|
2014
Q3 | $17.7M | Sell |
|
|||||
|
2014
Q2 | $25.2M | Buy |
|
|||||
|
2014
Q1 | $20.3M | Sell |
|
|||||
|
2013
Q4 | $17.2M | Sell |
|
|||||
|
2013
Q3 | $40M | Sell |
|
|||||
|
2013
Q2 | $35.2M | Buy |
|